Manufacturer record
Medley Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Medley Pharmaceuticals Ltd (Daman & Diu) were declared Not of Standard Quality between March 2023 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: E50058, Ofloxacin & Ornidazole Tablets IP (exp Dec 2028). SDTL, Assam (state lab) found it not of standard quality: The sample does not conform to I.P. w.r.to the tests for Dissolution And Assay. Listed in the April 2026 alert.
Records by type
5 records linked to Medley Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin & Ornidazole Tablets IP | Batch E50058Mfg Jan 2025 · Exp Dec 2028 | The sample does not conform to I.P. w.r.to the tests for Dissolution And AssayAssay | SDTL, AssamState lab | Apr 2026 |
| Haematinic Capsules (R.B. TONE) | Batch D40652Mfg Nov 2024 · Exp Oct 2026 | Microbial limit test (Total combined yeasts/molds count)Microbial limits | CDTL-MumbaiCDSCO lab | May 2025 |
| Pioglitazone Hydrochloride Tablets (GLITO 15) | Batch D40292Mfg May 2024 · Exp Apr 2027 | "Dissolution"Dissolution | CDTL MumbaiCDSCO lab | Apr 2025 |
| Ofloxacin & Ornidazole Tablets I.P. (O2) | Batch E20512Mfg Apr 2022 · Exp Mar 2025 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2023 |
| O2 (Ofloxacin & Ornidazole Tablets I.P.) | Batch E20034Mfg Jan 2022 · Exp Dec 2024 | Identification and Assay of Ofloxacin & OrnidazoleAssay | RDTL GuwahatiState lab | Mar 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.